AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furlan, P. M.
Right arrow Articles by Lucki, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furlan, P. M.
Right arrow Articles by Lucki, I.
Am J Geriatr Psychiatry 9:429-438, November 2001
© 2001 American Association for Geriatric Psychiatry


Regular Article

Cognitive and Psychomotor Effects of Paroxetine and Sertraline on Healthy Elderly Volunteers

Patricia M. Furlan, Ph.D., Michael J. Kallan, M.S., Thomas Ten Have, Ph.D., Bruce G. Pollock, M.D., Ph.D., Ira Katz, M.D., Ph.D., and Irwin Lucki, Ph.D.

Received March 9, 2001; revised May 20, June 12, 2001; accepted June 14, 2001. From the Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania. Address correspondence to Dr. Katz, University of Pennsylvania School of Medicine, Department of Psychiatry, 3600 Market St., Philadelphia, PA 19104. e-mail: katzi{at}mail.med.upenn.edu

The authors evaluated the cognitive and psychomotor effects of serotonin reuptake inhibitors in healthy elderly volunteers. Paroxetine, sertraline, and placebo were compared for 3 weeks of testing in a double-blind study with behavioral testing at baseline and at the end of each week. MANOVA models demonstrated no between-group differences; however, mixed-model random regression analyses revealed that Day 14 plasma paroxetine levels correlated negatively with delayed verbal recall and paired-associate learning scores. In contrast, plasma sertraline levels correlated positively with Day 7 immediate verbal recall, Day 14 tapping, and Day 21 delayed verbal recall scores, and negatively with divided-attention task scores on Day 21. Plasma paroxetine levels were associated with mild behavioral impairment at Day 14, with no other significant adverse effects. Plasma sertraline levels were associated with mild and transient behavioral changes, as well as early termination in several subjects.

Key Words: Selective Serotonin Reuptake Inhibitors (SSRIs) • Side Effects • Sertraline • Paroxetine




This article has been cited by other articles:


Home page
AJGPHome page
L. G. Chepenik, T. T. Have, D. Oslin, C. Datto, C. Zubritsky, and I. R. Katz
A Daily Diary Study of Late-Life Depression
Am J Geriatr Psychiatry, March 1, 2006; 14(3): 270 - 279.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
F. E. Lotrich and B. G. Pollock
Aging and Clinical Pharmacology: Implications for Antidepressants
J. Clin. Pharmacol., October 1, 2005; 45(10): 1106 - 1122.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
C. A. Munro, J. Brandt, J.-M. E. Sheppard, C. D. Steele, Q. M. Samus, M. Steinberg, P. V. Rabins, and C. G. Lyketsos
Cognitive Response to Pharmacological Treatment for Depression in Alzheimer Disease: Secondary Outcomes From the Depression in Alzheimer's Disease Study (DIADS)
Am J Geriatr Psychiatry, October 1, 2004; 12(5): 491 - 498.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
P. M. Furlan, M. J. Kallan, T. T. Have, I. Lucki, and I. Katz
SSRIs Do Not Cause Affective Blunting in Healthy Elderly Volunteers
Am J Geriatr Psychiatry, June 1, 2004; 12(3): 323 - 330.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
P. M. Doraiswamy, K. R. R. Krishnan, T. Oxman, L. R. Jenkyn, D. J. Coffey, T. Burt, and C. M. Clary
Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): M1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. D Joss, R. M Burton, and C. A Keller
Memory Loss in a Patient Treated with Fluoxetine
Ann. Pharmacother., December 1, 2003; 37(12): 1800 - 1803.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
B. G. Pollock
Biomarkers: From Bedside to Bench and Back Again
Am J Geriatr Psychiatry, December 1, 2002; 10(6): 644 - 645.
[Full Text] [PDF]


Home page
AJGPHome page
R. R. Bies, M. R. Gastonguay, K. C. Coley, P. D. Kroboth, and B. G. Pollock
Evaluating the Consistency of Pharmacotherapy Exposure by Use of State-of-the-Art Techniques
Am J Geriatr Psychiatry, December 1, 2002; 10(6): 696 - 705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2001 American Association for Geriatric Psychiatry